ESYT2 and breast carcinoma: Interestingly, at the protein level, the ER+ breast cancer cell lines investigated as well as the TNBC MDA-MB-231 cell line show enhanced E-Syt1 expression, and all the ER+ and TNBC cell lines investigated show E-Syt2 overexpression.